Immunetrics is a bio-simulation company, founded in 2001, that specializes in in silico disease modeling. Immunetrics modeling technology provides critical information to drug developers to accelerate and improve the drug discovery and development process, particularly in the identification of clinically relevant biomarkers. Immunetrics has developed a predictive software model of the human response to inflammation and coagulation, which enables drug discovery and development firms to gain comprehensive insights into a compound before investing significant resources into time-intensive and costly animal testing and human clinical trials.
https://www.immunetrics.com/
https://www.immunetrics.com/
Location: United States, Pennsylvania, Pittsburgh
Investors 2
| Date | Name | Website |
| - | Innovation... | innovation... |
| - | LaunchCyte | launchcyte... |
Mentions in press and media 4
| Date | Title | Description |
| 02.12.2020 | This Week in Jobs Pittsburgh: Did I really order that? | Hi! You’re reading the Pittsburgh edition of This Week in Jobs (TWIJ), a weekly newsletter written by our team at Technical.ly in partnership with InnovatePGH and the Pittsburgh Innovation District. Each week we put together for you a slate... |
| 01.09.2020 | This Week in Jobs Pittsburgh: Be more like Chadwick | Hi! You’re reading the Pittsburgh edition of This Week in Jobs (TWIJ), a weekly newsletter written by our team at Technical.ly in partnership with InnovatePGH and the Pittsburgh Innovation District. Each week we put together for you a slate... |
| 14.11.2012 | Drug developer advancing Phase 2 drug for Lou Gehrig’s disease raises $15M | Product: Its lead product is dexpramipexole for amyotrophic lateral sclerosis or Lou Gehrig’s disease and is being developed with Biogen. It is designed to protect stressed neurons and other cell types from dying, according to its website. ... |
| - | Drug developer advancing Phase 2 drug for Lou Gehrig’s disease raises $15M | Company name: Knopp Biosciences Industry: Biotechnology Location: Pittsburgh, Pennsylvania Product: Its lead product is dexpramipexole for amyotrophic lateral sclerosis or Lou Gehrig’s disease and is being developed with Biogen. It is desig... |